URZ3 Energy Welcomes Dr. Ivy Estabrooke to the Advisory Board

(TheNewswire)

Vancouver, B.C. - TheNewswire - December 1, 2025 – URZ3 Energy Corp.(TSX.V: URZ) (OTCQB: URZEF) (“ URZ3 ” or the“ Company ”) is pleased to announce Dr. Ivy V. Estabrooke has joinedURZ3 as a member of the Advisory Board.

“We are very pleased to welcome Dr. Estabrooke to theURZ3 Advisory Board. Her unique combination of national securityexperience, advanced technology leadership, and direct uranium-sectorboard experience will add tremendous depth to our strategic planning.Ivy’s background in deploying innovation at scale—particularly inhighly regulated environments—aligns perfectly with our vision as weadvance URZ3’s U.S.-focused uranium strategy,” stated Darcy Higgs,Director.

About Ivy V. Estabrooke, BA, MS,PhD

Ivy Estabrooke is an innovation executive with years ofstrategy, oversight, and leadership experience in technologydevelopment and deployment in national security and health careenvironments. Dr. Estabrooke serves on the board of Rare EarthsAmericas, an exploration stage rare earth company and previouslyserved on the board of Energy Fuels Inc. (NYSE: UUUU; TSX: EFR), aproducer of uranium, vanadium, and rare earth minerals. She has servedon numerous nonprofit boards, including the Girl Scouts of Utah,BioUtah, and the Utah District Export Council. Dr. Estabrooke startedher career leading a technology development portfolio for the USDepartment of the Navy where she fielded cutting-edge tools to the USMarine Corps, intelligence community, and Special Forces community.She was the executive director of the Utah Science Technology andResearch Initiative, a technology-based economic development agency,senior advisor to the Governor of Utah, and an executive at multiplebiotech start-ups. She currently advises government, public, andprivate entities in optimizing their approaches to innovation andtechnology development for national security, economic, and socialimpact in her role as Strategic Account Executive - Defense for RTIInternational, an independent scientific research institute. She holdsthe NACD.DC and Department of Defense Senior Acquisition Professionalcertifications.

Dr. Estabrooke is a member of advisory boards atArizona State University and The University of Texas at Arlington. Sheis on the board of the Utah chapter of the National Association ofCorporate Directors and the Utah District Export Council.

Dr. Estabrooke has a doctorate in neuroscience fromGeorgetown University, a master’s degree in national resourcemanagement from the National Defense University and a bachelor'sdegree in biological sciences from Smith College. Her leadership hasbeen recognized with the US Navy Meritorious Service Award, the Fed100, and a Pathfinder Award.

Corporate

The Company also announces that, pursuant to its stockoption plan and subject to regulatory acceptance, it has granted anaggregate total of 100,000 incentive stock options to Dr. Estabrooke,subject to certain vesting provisions. These options will beexercisable at a price of $0.335 per common share and will expire onNovember 28, 2030.

The stock option grant is subjectto the receipt of all necessary regulatory filings and TSX-Vapprovals.

About URZ3 Energy Corp.

URZ3 Energy Corp. is a resource development companyfocused on the acquisition and exploration of uranium properties inNorth America. The Company is dedicated to advancing its portfolio ofprojects to meet the growing demand for uranium as a clean energyresource, leveraging its team’s extensive experience in ISR uraniumexploration, development, and production.

For more information about URZ3 Energy Corp., pleasevisit www.urz3.com .

Contact:

Mark Kolebaba, President andCEO

Telephone: (604) 307-6450
Email: info@URZ3.com

Neither the TSX Venture Exchange nor its RegulationServices Provider (as that term is defined in the policies of the TSXVenture Exchange) accepts responsibility for the adequacy or accuracyof this release.

Cautionary statement regarding forward–lookinginformation

Certain disclosuresin this release constitute “forward-looking information” withinthe meaning of Canadian securities legislation (such statements beingreferred to as “forward-looking statements”). Forward-lookingstatements are statements that are not historical facts and aregenerally, but not always, identified by words such as the following:expects, plans, anticipates, believes, intends, estimates, projects,assumes, potential and similar expressions. Forward-looking statementsinvolve risks, uncertainties and other factors that could cause actualresults, performance, prospects and opportunities to differ materiallyfrom those expressed or implied by such forward-lookingstatements. Factors that could cause actual results to differmaterially from these forward-looking statements include, but are notlimited to, variations in the nature, quality and quantity of anymineral deposits that may be located, the Company’s inability toobtain any necessary permits, consents or authorizations required forits planned activities, and the Company’s inability to raise thenecessary capital or to be fully able to implement its businessstrategies. The reader is referred to the Company’s publicdisclosure record which is available on SEDAR+ ( sedarplus.ca ).  Although the Companybelieves that the assumptions and factors used in preparing theforward-looking statements are reasonable, undue reliance should notbe placed on these statements, which only apply as of the date of thisnews release, and no assurance can be given that such events willoccur in the disclosed time frames or at all.  Except as required bysecurities laws and the policies of the TSX Venture Exchange, theCompany disclaims any intention or obligation to update or revise anyforward-looking statement, whether as a result of new information,future events or otherwise.

Copyright (c) 2025 TheNewswire - All rights reserved.